Learn about rheumatoid vasculitis, neutrophilic dermatoses, and other rheumatoid arthritis rashes, their symptoms, and when ...

Osteoarthritis is caused by the breakdown of cartilage that cushions your joints. Rheumatoid arthritis is an autoimmune disease in which your immune system attacks your body's own tissues in the ...

The classic signs of rheumatoid arthritis include pain, swelling, and stiffness of several joints. Persistent inflammation can lead to issues with mobility, fatigue, illness, and joint deformity over ...

Anumigilimab (CSL324) is under development for the treatment of Coronavirus disease 2019 (COVID-19), cancer, inflammatory diseases associated with neutrophil infiltration including chronic obstructive ...

Vulvar dermatitis is a skin condition that affects the skin of the vulva. The vulva is the external female genitalia, which includes the labia, clitoris, and vaginal opening. People with vulvar ...

This means that this advanced goal of remaining in a good health status in regard to rheumatoid arthritis, which should be imminent in the definition of remission, but without the risks associated ...

The failure of ANB032 in Phase 2B for atopic dermatitis has shifted focus to ... Rosnilimab's upcoming Phase 2B results for rheumatoid arthritis in February 2025 are crucial, but Eli Lilly's ...

Robert Douglas Sweet described this disease in eight women in 1964, under the explicit term "acute febrile neutrophilic dermatosis" (Sweet, 1964). SS is the most frequent of the ND. Definition.

ANB032 was well tolerated across all doses with no safety signals observed AD trial and all further investment in ANB032 will be discontinued Anticipate top-line Phase 2b data in rheumatoid arthritis ...

We look forward to sharing for rosnilimab, a depleter and agonist targeting PD-1+ T cells, top-line Phase 2b rheumatoid arthritis ... atopic dermatitis and headache. “We are sincerely grateful ...

Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative neoplasm characterized by CSF3R mutations. Here, we report the first case of a CNL patient positive for a de-novo germline CSF3R T618I ...